Research Topics
| Jennifer T LoudSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer familiesSusan T Vadaparampil
Division of Population Sciences, Moffitt Cancer Center, Tampa, Flordia, USA
Hered Cancer Clin Pract 7:11. 2009..Our data provide a basis for further exploring psychosocial issues that are specific to men with a family history of TC, and formulating intervention strategies aimed at improving adherence to TSE guidelines...
Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancerJennifer T Loud
Clinical Genetics Branch, National Cancer Institute, NIH, Rockville, MD, USA
BMC Womens Health 9:20. 2009..We report DL tolerability in BRCA1/2 mutation-positive and -negative women from an IRB-approved research study...
Applications of advances in molecular biology and genomics to clinical cancer careJennifer T Loud
Clinical Genetics Branch CGB, National Cancer Institute, National Institutes of Health, Rockville, MD 20852, USA
Cancer Nurs 25:110-22; quiz 123-4. 2002..We use specific examples to demonstrate the use of genetic information to achieve these objectives and to illustrate principles and strategies that may be applied to a variety of cancers...
Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?Jennifer T Loud
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD 20852, USA
Cancer Epidemiol Biomarkers Prev 18:1243-51. 2009..Little is known about patient characteristics associated with obtaining nipple aspirate fluid (NAF) and adequate cell counts (> or =10 cells) in ductal lavage specimens from BRCA mutation carriers...
Deliberate deceit of family members: a challenge to providers of clinical genetics servicesJennifer T Loud
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services; Food and Drug Administration, Rockville, MD 20853-7231, USA
J Clin Oncol 24:1643-6. 2006
Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility familiesJune A Peters
Clinical Genetics Branch CGB, Division of Cancer Epidemiology and Genetics DCEG, National Cancer Institute NCI, National Institutes of Health NIH, Department of Health and Human Services DHHS, Rockville, MD 20852, USA
J Genet Couns 20:450-64. 2011..Blocking often seemed to involve bi-directional feedback loops, in keeping with Lepore's Social Constraints and Modulation Theory. Privacy and protectiveness predominated as explanations for long-term blocking...
BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experienceAlexis D Bakos
Department of Health and Human Services, National Institute of Nursing Research, NIH, Rockville, MD, USA
Health Expect 11:220-31. 2008..This study was designed to explore cancer risk perception and the experience of being a mutation-negative woman within a known BRCA1/2 mutation-positive family...
Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventionsLaura M Koehly
Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, Building 31, Room B1B37D, 31 Center Drive MSC 2073, Bethesda, MD 20892, USA
Am J Public Health 99:2203-9. 2009..Given the importance of the dissemination of accurate family history to assess disease risk, we characterized the gatherers, disseminators, and blockers of health information within families at high genetic risk of cancer...
Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancerGretchen L Gierach
Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Breast Cancer Res Treat 123:245-55. 2010..Taking these factors into account did not significantly alter the results of the age/body mass index-adjusted analysis. Our results do not provide support for an independent effect of BRCA1/2 mutation status on mammographic density...
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort studyBlanche P Alter
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852 7231, USA
Br J Haematol 150:179-88. 2010..The findings demonstrate that both FA and DC are major cancer susceptibility syndromes. The IBMFS, historically considered paediatric disorders, have important management implications for physicians treating adult patients...
Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancerChristine M Mueller
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
BMC Complement Altern Med 8:17. 2008..Complementary and alternative medicine (CAM) use is well documented among breast cancer patients and survivors, but little evidence is available to describe rates and patterns of use among women at increased genetic risk of breast cancer...
Testicular cancer and genetics knowledge among familial testicular cancer family membersJune A Peters
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 6120 Executive Blvd, EPS 7026, Rockville, MD 20852, USA
J Genet Couns 17:351-64. 2008..It was our aim to determine baseline levels of testicular cancer and genetics knowledge among members of families with Familial Testicular Cancer (FTC)...
